Literature DB >> 8129707

Proteolytic degradation of the RGD-binding and non-RGD-binding conformers of human platelet integrin glycoprotein IIb/IIIa: clues for identification of regions involved in the receptor's activation.

J J Calvete1, K Mann, W Schäfer, R Fernandez-Lafuente, J M Guisán.   

Abstract

The human integrin glycoprotein (GP)IIb/IIIa plays a central role in haemostasis as an inducible receptor for fibrinogen and other RGD-containing adhesive proteins at the platelet plasma membrane. Expression of the fibrinogen receptor on platelet activation involves conformational changes in the quaternary structure of GPIIb/IIIa. Little is known, however, about the nature of this conformational transition. Given that isolated GPIIb/IIIa contains a mixture of RGD-binding and non-RGD-binding heterodimers, we used limited proteolysis as a tool for investigating the structural differences between the two conformers. Comparison of their fragmentation patterns shows that, whereas in the non-RGD-binding form of GPIIb/IIIa the N-terminal half of the heavy chain of GPIIb (GPIIbH) and the central region of GPIIIa are cleaved by endoproteinase Arg-C, these domains associate tightly with one another in the RGD-binding GPIIb/IIIa and are thus protected from proteolysis. In addition, the C-terminal half of GPIIb becomes more susceptible to degradation in the non-RGD-binding GPIIb/IIIa conformer. Our interpretation, in the context of available structural and functional data, is that a major relative reorientation of the GPIIbH and GPIIIa extracellular domains takes place along the subunit interface during the conformational transition of the platelet integrin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8129707      PMCID: PMC1137975          DOI: 10.1042/bj2980001

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  59 in total

Review 1.  GPIIb-IIIa: the responsive integrin.

Authors:  D R Phillips; I F Charo; R M Scarborough
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

Review 2.  The use of monoclonal antibodies and limited proteolysis in elucidation of structure-function relationships in proteins.

Authors:  J E Wilson
Journal:  Methods Biochem Anal       Date:  1991

3.  Affinity modulation of the alpha IIb beta 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor.

Authors:  T E O'Toole; J C Loftus; X P Du; A A Glass; Z M Ruggeri; S J Shattil; E F Plow; M H Ginsberg
Journal:  Cell Regul       Date:  1990-11

4.  Three-dimensional structure of echistatin, the smallest active RGD protein.

Authors:  V Saudek; R A Atkinson; J T Pelton
Journal:  Biochemistry       Date:  1991-07-30       Impact factor: 3.162

5.  Monoclonal antibodies to ligand-occupied conformers of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function.

Authors:  A L Frelinger; X P Du; E F Plow; M H Ginsberg
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.157

6.  The effect of glycoprotein IIb-IIIa receptor occupancy on the cytoskeleton of resting and activated platelets.

Authors:  W C Kouns; C F Fox; W J Lamoreaux; L B Coons; L K Jennings
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

7.  Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex.

Authors:  P J Sims; M H Ginsberg; E F Plow; S J Shattil
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

8.  A highly conserved sequence of the Arg-Gly-Asp-binding domain of the integrin beta 3 subunit is sensitive to stimulation.

Authors:  A Andrieux; M J Rabiet; A Chapel; E Concord; G Marguerie
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

9.  Localization of the cross-linking sites of RGD and KQAGDV peptides to the isolated fibrinogen receptor, the human platelet integrin glycoprotein IIb/IIIa. Influence of peptide length.

Authors:  J J Calvete; W Schäfer; K Mann; A Henschen; J González-Rodríguez
Journal:  Eur J Biochem       Date:  1992-06-15

10.  Solution structure of kistrin, a potent platelet aggregation inhibitor and GP IIb-IIIa antagonist.

Authors:  M Adler; R A Lazarus; M S Dennis; G Wagner
Journal:  Science       Date:  1991-07-26       Impact factor: 47.728

View more
  1 in total

1.  Conformational changes in tertiary structure near the ligand binding site of an integrin I domain.

Authors:  C Oxvig; C Lu; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.